Effects of Osmotic-Release Methylphenidate on Height and Weight in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Following up to Four Years of Treatment
There is some controversy concerning \the potential negative influence of methylphenidate on growth. The authors reviewed clinical records of 187 patients with attention-deficit hyperactivity disorder under treatment with methylphenidate. The patients’ weight, height, and body mass index were measured at diagnosis and during 4 years of follow-up. The dose of methylphenidate was gradually increased up to 1.31 + 0.2 mg/kg/d. At diagnosis, mean weight value was lower than mean weight expected for age by 0.697 kg. This difference increased to 4.274 kg (at 30 months of treatment), although it subsequently decreased to 1.588 kg (at 48 months of treatment). Mean value of height was lower than expected mean height for age by 0.42 cm at diagnosis. This difference increased to 2.69 cm (at 30 months of treatment), but it subsequently decreased to 0.83 cm (at 48 months of treatment). The relationship between nutritional status and the negative effects on the height curve in those patients would require nutritional optimization to return anthropometric variables to normal.
|Autor:||Durá-Travé et al.|
|Quelle:||Journal of Child Neurology, 27(5) 604-609|
|Keywords (englisch):||attention-deficit hyperactivity disorder, body mass index, height, methylphenidate, weight, ADHD|